Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Visa
V
|
+$55.5M |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
+$35.4M |
| 3 |
International Paper
IP
|
+$25.3M |
| 4 |
DoorDash
DASH
|
+$21.9M |
| 5 |
Natera
NTRA
|
+$17.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$712M |
| 2 |
Apple
AAPL
|
+$120M |
| 3 |
Interactive Brokers
IBKR
|
+$38.1M |
| 4 |
NVIDIA
NVDA
|
+$24.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
Sector Composition
| 1 | Technology | 31.47% |
| 2 | Healthcare | 11.82% |
| 3 | Consumer Discretionary | 11.72% |
| 4 | Communication Services | 9.55% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRP.U
1551
Granite Real Estate Investment Trust
GRP.U
$3.37B
| $2.96M | ﹤0.01% |
63,500
| – | – |
|
1552
Integra LifeSciences
IART
$1.16B
| $2.96M | ﹤0.01% |
134,594
+4,900
| +4% | +$108K |
|
1553
Lakeland Financial Corp
LKFN
$1.63B
| $2.94M | ﹤0.01% |
49,450
-700
| -1% | -$41.6K |
|
1554
NETSCOUT
NTCT
$1.82B
| $2.92M | ﹤0.01% |
139,028
-1,100
| -0.8% | -$23.1K |
|
1555
Reynolds Consumer Products
REYN
$4.85B
| $2.92M | ﹤0.01% |
122,200
-1,800
| -1% | -$42.9K |
|
1556
Agios Pharmaceuticals
AGIO
$2.12B
| $2.91M | ﹤0.01% |
99,460
-1,300
| -1% | -$38.1K |
|
|
MAG
1557
DELISTED
MAG Silver
MAG
| $2.91M | ﹤0.01% |
191,300
-2,600
| -1% | -$39.6K |
|
1558
Apellis Pharmaceuticals
APLS
$3.01B
| $2.9M | ﹤0.01% |
132,600
-11,100
| -8% | -$243K |
|
1559
Nicolet Bankshares
NIC
$1.97B
| $2.9M | ﹤0.01% |
26,600
| – | – |
|
1560
Customers Bancorp
CUBI
$2.27B
| $2.9M | ﹤0.01% |
57,700
-1,500
| -3% | -$75.3K |
|
1561
AvePoint
AVPT
$3.27B
| $2.89M | ﹤0.01% |
199,800
-2,200
| -1% | -$31.8K |
|
1562
Pitney Bowes
PBI
$1.96B
| $2.88M | ﹤0.01% |
317,800
| – | – |
|
1563
Hilltop Holdings
HTH
$2.13B
| $2.87M | ﹤0.01% |
94,400
-1,200
| -1% | -$36.5K |
|
1564
AvidXchange
AVDX
$2.07B
| $2.87M | ﹤0.01% |
338,800
+11,800
| +4% | +$100K |
|
1565
IES Holdings
IESC
$7.1B
| $2.87M | ﹤0.01% |
17,400
-200
| -1% | -$33K |
|
1566
BioCryst Pharmaceuticals
BCRX
$1.62B
| $2.86M | ﹤0.01% |
381,268
-5,300
| -1% | -$39.8K |
|
1567
ODDITY Tech
ODD
$3.47B
| $2.86M | ﹤0.01% |
66,100
+3,900
| +6% | +$169K |
|
1568
Carter's
CRI
$1.16B
| $2.85M | ﹤0.01% |
69,800
-1,400
| -2% | -$57.3K |
|
1569
Tarsus Pharmaceuticals
TARS
$2.18B
| $2.85M | ﹤0.01% |
55,533
+3,200
| +6% | +$164K |
|
|
SILA
1570
Sila Realty Trust, Inc.
SILA
$1.4B
| $2.85M | ﹤0.01% |
+106,581
| New | +$2.85M |
|
1571
Levi Strauss
LEVI
$8.98B
| $2.85M | ﹤0.01% |
182,600
-2,200
| -1% | -$34.3K |
|
1572
NuScale Power
SMR
$4.84B
| $2.83M | ﹤0.01% |
200,100
+32,400
| +19% | +$459K |
|
1573
Travere Therapeutics
TVTX
$2.03B
| $2.83M | ﹤0.01% |
158,100
+6,200
| +4% | +$111K |
|
1574
GeneDx Holdings
WGS
$3.67B
| $2.83M | ﹤0.01% |
31,900
+8,100
| +34% | +$717K |
|
1575
National Bank Holdings
NBHC
$1.43B
| $2.82M | ﹤0.01% |
73,700
-800
| -1% | -$30.6K |
|